DK1052259T3 - Optisk aktivt aminopentanderivat - Google Patents

Optisk aktivt aminopentanderivat

Info

Publication number
DK1052259T3
DK1052259T3 DK99947940T DK99947940T DK1052259T3 DK 1052259 T3 DK1052259 T3 DK 1052259T3 DK 99947940 T DK99947940 T DK 99947940T DK 99947940 T DK99947940 T DK 99947940T DK 1052259 T3 DK1052259 T3 DK 1052259T3
Authority
DK
Denmark
Prior art keywords
optically active
disease
composition
aminopentane derivative
active aminopentane
Prior art date
Application number
DK99947940T
Other languages
Danish (da)
English (en)
Inventor
Fumio Yoneda
Joseph Knoll
Hironori Ohde
Masatoshi Sakae
Toshiaki Moto
Takashi Ando
Seiichiro Shimazu
Kazue Takahata
Original Assignee
Fujimoto Brothers Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujimoto Brothers Co Ltd filed Critical Fujimoto Brothers Co Ltd
Application granted granted Critical
Publication of DK1052259T3 publication Critical patent/DK1052259T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/81Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)
DK99947940T 1998-10-29 1999-10-15 Optisk aktivt aminopentanderivat DK1052259T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP34775698A JP4499208B2 (ja) 1998-10-29 1998-10-29 新規な光学活性アミノペンタン誘導体
PCT/JP1999/005729 WO2000026204A1 (fr) 1998-10-29 1999-10-15 Nouveau derive d'aminopentane optiquement actif

Publications (1)

Publication Number Publication Date
DK1052259T3 true DK1052259T3 (da) 2007-08-06

Family

ID=18392375

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99947940T DK1052259T3 (da) 1998-10-29 1999-10-15 Optisk aktivt aminopentanderivat

Country Status (17)

Country Link
US (1) US6391914B1 (ko)
EP (1) EP1052259B1 (ko)
JP (1) JP4499208B2 (ko)
KR (1) KR100603112B1 (ko)
CN (1) CN1131858C (ko)
AT (1) ATE360009T1 (ko)
AU (1) AU762995B2 (ko)
CA (1) CA2317036C (ko)
DE (1) DE69935849T2 (ko)
DK (1) DK1052259T3 (ko)
ES (1) ES2285861T3 (ko)
HK (1) HK1032585A1 (ko)
HU (1) HU228299B1 (ko)
IL (1) IL136977A0 (ko)
PT (1) PT1052259E (ko)
SI (1) SI20209A (ko)
WO (1) WO2000026204A1 (ko)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4691230B2 (ja) * 2000-04-11 2011-06-01 株式会社フジモト・コーポレーション 光学活性1−(ベンゾフラン−2−イル)−2−プロピルアミノペンタンの製造方法
JP4888751B2 (ja) * 2001-09-14 2012-02-29 株式会社フジモト・コーポレーション トリフルオロプロピルアミノペンタン誘導体及びその製造方法
JP4953040B2 (ja) * 2001-09-19 2012-06-13 株式会社フジモト・コーポレーション アポトーシス抑制剤
JP5030194B2 (ja) * 2004-11-25 2012-09-19 国立大学法人九州大学 薬物依存症治療剤
KR101500022B1 (ko) * 2007-06-21 2015-03-06 가부시키가이샤 후지모토 코포레이션 경피 또는 경점막 투여용 조성물
AU2014371437B2 (en) * 2013-12-25 2020-01-30 Fujimoto Co., Ltd. Prophylactic and therapeutic agent for attention-deficit/hyperactivity disorder
HUE050756T2 (hu) 2014-12-05 2021-01-28 Semmelweis Univ Arilalkilamin vegyületek rák megelõzésében vagy kezelésében történõ alkalmazásra

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU207280B (en) * 1986-09-25 1993-03-29 Chinoin Gyogyszer Es Vegyeszet Process for producing new phenyl-alkyl-amines and pharmaceutical compositions containing them
HUT63579A (en) * 1991-12-20 1993-09-28 Chinoin Gyogyszer Es Vegyeszet Process for producing double-phase pharmaceutical compositions suitable for treating diseases occurring during neurodegenerative processes
JPH0859578A (ja) * 1994-06-17 1996-03-05 Taisho Pharmaceut Co Ltd 置換フェニルアルキルアミン誘導体
AU747737B2 (en) 1997-08-07 2002-05-23 Fujimoto Co., Ltd. Novel ethylamine derivatives

Also Published As

Publication number Publication date
AU762995B2 (en) 2003-07-10
EP1052259A1 (en) 2000-11-15
HUP0004667A2 (hu) 2001-04-28
WO2000026204A1 (fr) 2000-05-11
KR20010033756A (ko) 2001-04-25
KR100603112B1 (ko) 2006-07-20
HU228299B1 (en) 2013-03-28
ATE360009T1 (de) 2007-05-15
JP2000136187A (ja) 2000-05-16
DE69935849D1 (de) 2007-05-31
HK1032585A1 (en) 2001-07-27
IL136977A0 (en) 2001-06-14
AU6124199A (en) 2000-05-22
JP4499208B2 (ja) 2010-07-07
EP1052259A4 (en) 2001-10-24
EP1052259B1 (en) 2007-04-18
ES2285861T3 (es) 2007-11-16
DE69935849T2 (de) 2008-01-10
CN1287554A (zh) 2001-03-14
CA2317036A1 (en) 2000-05-11
CA2317036C (en) 2009-05-19
PT1052259E (pt) 2007-07-20
US6391914B1 (en) 2002-05-21
CN1131858C (zh) 2003-12-24
SI20209A (sl) 2000-10-31
HUP0004667A3 (en) 2001-10-29

Similar Documents

Publication Publication Date Title
BR9914638A (pt) Composto, método para a preparação do mesmo, composição farmacêutica, uso de um composto, e, método para o tratamento de um distúrbio ou doença de um corpo de animal vivo
MY138252A (en) Azabicyclic-substitud fused-heteroaryl compounds for the treatment of disease
NO20063275L (no) Anvendelse av substituerte 2-aminotetraliner for forebyggende behandling av Parkinsons sykdom
DK1780197T3 (da) 5-Substituerede 2-phenylamino-benzamider som MEK-inhibitorer
EA200301216A1 (ru) Замещенные хинуклидинами мультициклические гетероарилы для лечения заболевания
ES2196527T3 (es) Derivados de 11,15-o-dialquilprostaglandina e, su procedimiento de produccion y medicamentos que incluyen estos como principio activo.
ATE260255T1 (de) 5-oxo-pyrrolidine-2-carbonsäure- hydroxamidderivate
UY26813A1 (es) Compuestos para tratar enfermedad de alzheimer
BG105112A (en) Agents with antidepressive effect
PT669920E (pt) 3-aminoalquilamino-1,2-benzoxazoles substituidos ecompostos relacionados
DE60012751D1 (de) Verwendung von ep4 rezeptorliganden zur behandlung von neuropathischen schmerz
BR0206495A (pt) Tratamento de distúrbios de cns empregando antagonistas de oxidase de d-aminoácido e oxidase de d-aspartato
PE20080364A1 (es) Acido bifenilcarboxilicos substituidos y sus derivados como moduladores de la actividad de la gamma-secretasa
EA200300716A1 (ru) Гетероциклилалкилиндольные или -азаиндольные соединения в качестве лиганд 5-гидрокситриптамина-6
NO20021875L (no) Fremgangsmåte for stabilisering av benzimidazolforbindelser
DE69835004D1 (de) Neue ethylaminderivate
MX2009004898A (es) Derivados de indol y de benzofurano-2-carboxamida.
DK1052259T3 (da) Optisk aktivt aminopentanderivat
ATE523498T1 (de) Hiv-inhibierende 2-(4- cyanophenylamino)pyrimidinderivate
BR0011728A (pt) Método de inibir a agregação de proteìna amilóide e imagem de depósitos de amilóide
DK0966277T3 (da) Anvendelse af R-NSAID'er til forebyggelse af Alzheimer's sygdom
DE60002583D1 (de) Benzofurylpiperazine als serotonin-agonisten
DK1174131T3 (da) Anvendelse af et middel til forbedring af astrocytfunktion til behandling af Parkinsons sygdom
BR0110871A (pt) Derivados de sulfonamida
PT804186E (pt) Compostos alcaloides diterpenicos de indole